Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP268296.RACqa4Ws4_3XFfTK1lQ-IeGBWfrFgrd3lj5OXSw7c3FEI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP268296.RACqa4Ws4_3XFfTK1lQ-IeGBWfrFgrd3lj5OXSw7c3FEI130_assertion type Assertion NP268296.RACqa4Ws4_3XFfTK1lQ-IeGBWfrFgrd3lj5OXSw7c3FEI130_head.
- NP268296.RACqa4Ws4_3XFfTK1lQ-IeGBWfrFgrd3lj5OXSw7c3FEI130_assertion description "[We analyzed TMPRSS2-ERG gene rearrangement status by fluorescence in situ hybridization in 521 cases of clinically localized surgically treated prostate cancer with 95 months of median follow-up and also in 40 unmatched metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268296.RACqa4Ws4_3XFfTK1lQ-IeGBWfrFgrd3lj5OXSw7c3FEI130_provenance.
- NP268296.RACqa4Ws4_3XFfTK1lQ-IeGBWfrFgrd3lj5OXSw7c3FEI130_assertion evidence source_evidence_literature NP268296.RACqa4Ws4_3XFfTK1lQ-IeGBWfrFgrd3lj5OXSw7c3FEI130_provenance.
- NP268296.RACqa4Ws4_3XFfTK1lQ-IeGBWfrFgrd3lj5OXSw7c3FEI130_assertion SIO_000772 19190343 NP268296.RACqa4Ws4_3XFfTK1lQ-IeGBWfrFgrd3lj5OXSw7c3FEI130_provenance.
- NP268296.RACqa4Ws4_3XFfTK1lQ-IeGBWfrFgrd3lj5OXSw7c3FEI130_assertion wasDerivedFrom befree-20140225 NP268296.RACqa4Ws4_3XFfTK1lQ-IeGBWfrFgrd3lj5OXSw7c3FEI130_provenance.
- NP268296.RACqa4Ws4_3XFfTK1lQ-IeGBWfrFgrd3lj5OXSw7c3FEI130_assertion wasGeneratedBy ECO_0000203 NP268296.RACqa4Ws4_3XFfTK1lQ-IeGBWfrFgrd3lj5OXSw7c3FEI130_provenance.